UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma

Annals of oncology, 2014-06, Vol.25 (6), p.1204-1208

2014

Volltextzugriff (PDF)

A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

Annals of oncology, 2012-05, Vol.23 (5), p.1287-1292

2012

Volltextzugriff (PDF)

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.452-465

2021

Volltextzugriff (PDF)

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation

Annals of oncology, 2011-06, Vol.22 (6), p.1280-1287

2011

Volltextzugriff (PDF)

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

Investigational new drugs, 2015-08, Vol.33 (4), p.985-991

2015

Volltextzugriff (PDF)

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms

Annals of oncology, 2009-11, Vol.20 (11), p.1854-1859

2009

Volltextzugriff (PDF)

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii83-vii85

2012

Volltextzugriff (PDF)

At-home Chemotherapy Infusion for Patients with Advanced Cancer in Hong Kong

Hong Kong journal of radiology : HKJR = Xianggang fang she ke yi xue za zhi, 2020-06, Vol.23 (2), p.122-129

2020

Volltextzugriff (PDF)

FGF8b oncogene mediates proliferation and invasion of Epstein–Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation

Oncogene, 2011-03, Vol.30 (13), p.1518-1530

2011

Volltextzugriff (PDF)

Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy

Annals of oncology, 2020-06, Vol.31 (6), p.769-779

2020

Volltextzugriff (PDF)

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma

Annals of oncology, 2022-08, Vol.33 (8), p.794-803

2022

Volltextzugriff (PDF)

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma

Annals of oncology, 2019-06, Vol.30 (6), p.977-982

2019

Volltextzugriff (PDF)

Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients

British journal of cancer, 2011-03, Vol.104 (6), p.1000-1006

2011

Volltextzugriff (PDF)

Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx

American journal of neuroradiology : AJNR, 2020-12, Vol.41 (12), p.2339-2344

2020

Volltextzugriff (PDF)

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma

American journal of neuroradiology : AJNR, 2020-03, Vol.41 (3), p.515-521

2020

Volltextzugriff (PDF)

CD4+ T-Cell Responses to Epstein-Barr Virus Nuclear Antigen EBNA1 in Chinese Populations Are Highly Focused on Novel C-Terminal Domain-Derived Epitopes

Journal of Virology, 2006-08, Vol.80 (16), p.8263-8266

2006

Volltextzugriff (PDF)

A pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo

Annals of oncology, 2018-11, Vol.29, p.ix35-ix35

2018

Volltextzugriff (PDF)

Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinoma

ESMO open, 2024-10, Vol.9 (10), p.103933, Article 103933

2024

Volltextzugriff (PDF)

Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening

Hong Kong Medical Journal, 2022-04, Vol.28 (2), p.161

2022

Volltextzugriff (PDF)

Recommendations on prevention and screening for colorectal cancer in Hong Kong

Hong Kong medical journal = Xianggang yi xue za zhi, 2018-10, Vol.24 (5), p.521-526

2018

Volltextzugriff (PDF)

Recommendations on prevention and screening for breast cancer in Hong Kong

Hong Kong medical journal = Xianggang yi xue za zhi, 2018-06, Vol.24 (3), p.298-306

2018

Volltextzugriff (PDF)

Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2007-05, Vol.18 (suppl-2), p.ii67-ii68

2007

Volltextzugriff (PDF)

Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong

Hong Kong medical journal = Xianggang yi xue za zhi, 2010-06, Vol.16 Suppl 3, p.34-37

2010

Volltextzugriff (PDF)

108PA pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Volltextzugriff (PDF)

Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation

Annals of oncology, 2016-10, Vol.27, p.vi332-vi332

2016

Volltextzugriff (PDF)

1 – 25 von 3.547

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.207)
Mit Volltextzugriff
(3.041)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.636)
Life Sciences & Biomedicine
(1.808)
Humans
(1.360)
Female
(789)
Male
(763)
Biological And Medical Sciences
(678)
Animals
(609)
Physical Sciences
(564)
Medical Sciences
(501)
Middle Aged
(444)
Adult
(437)
Technology
(336)
Aged
(333)
Mice
(315)
Biochemistry & Molecular Biology
(255)
Physics
(251)
Fundamental And Applied Biological Sciences. Psychology
(238)
Oncology
(212)
Chemistry
(208)
Science & Technology - Other Topics
(207)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma

A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

At-home Chemotherapy Infusion for Patients with Advanced Cancer in Hong Kong

FGF8b oncogene mediates proliferation and invasion of Epstein–Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation

Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy

Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma

Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients

Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma

CD4+ T-Cell Responses to Epstein-Barr Virus Nuclear Antigen EBNA1 in Chinese Populations Are Highly Focused on Novel C-Terminal Domain-Derived Epitopes

A pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo

Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinoma

Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening

Recommendations on prevention and screening for colorectal cancer in Hong Kong

Recommendations on prevention and screening for breast cancer in Hong Kong

Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong

108PA pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo

Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation

Suchergebnisse filtern